CSTL – castle biosciences, inc. - common stock (US:NASDAQ)

News

Castle Biosciences (CSTL) was given a new $40.00 price target by Canaccord Genuity Group Inc..
The Melanoma Research Foundation Launches its Inaugural Washington DC 5K Fundraiser with a Goal of $115,000 in Support of Melanoma Research, Education and Advocacy
Castle Biosciences inks expansion at Nova Place [Yahoo! Finance]
Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026 [TheStreet.com]
Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com